Global intellectual property protection of “innovative” pharmaceuticals (original) (raw)
The Global Regime of Intellectual Property Rights. An interpretation grounded in their social function. The case of pharmaceutical patents
Mikel Diez Sarasola
2017
View PDFchevron_right
World policy battles on pharmaceutical patent protection : micro-history of a forum shift and its legal implications
Pablo Zapatero
2013
View PDFchevron_right
The dynamics of knowledge accumulation, regulation, and appropriability in the pharma-biotech sector: policy issues
Giovanni Dosi
The Case of Pharma-Biotech, 2006
View PDFchevron_right
New Forms of Dialectics Between Intellectual Property and Public Health : Pharmaceutical Patent-Related Investment Disputes
valentina vadi
International Lawyer, 2016
View PDFchevron_right
Balancing intellectual monopoly privileges and the need for essential medicines
Thomas Faunce
Globalization and Health, 2007
View PDFchevron_right
Just Rules for Innovative Pharmaceuticals
Thomas Pogge
Philosophies
View PDFchevron_right
Tightening Appropriability Through the Patenting Process: An Exploratory Analysis of Pharmaceuticals
Henrique M Barros
REAd - Revista Eletrônica de Administração, 2010
View PDFchevron_right
Pharmaceutical Patents and Economic Ineqality
Thomas Pogge
Health and Human Rights, 2023
View PDFchevron_right
Ownership of knowledge--the role of patents in pharmaceutical R&D
carlos correa
Bulletin of The World Health Organization, 2004
View PDFchevron_right
Approaching Pharmaceutical Patent Enforcement Using Intellectual Property Rights and Product Innovation
Soaad Hossain
View PDFchevron_right
Monopoly v. Openness: Two sides of IP coin in the pharmaceutical industry
Olga Gurgula
The Journal of World Intellectual Property, 2017
View PDFchevron_right
Drugs in a brave new world of trips+ schemes : the case for legal ceilings on extra patent protection
Pablo Zapatero
2013
View PDFchevron_right
Commentary to "Patients not patents: drug research and development as a public enterprise
Gerard Raj
European journal of clinical investigation, 2017
View PDFchevron_right
Intellectual Property and Pharmaceutical Drugs: An Ethical Analysis
Richard George
Business Ethics Quarterly, 2005
View PDFchevron_right
Comment: Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Jerome Reichman
The Journal of Law, Medicine & Ethics, 2009
View PDFchevron_right
Patents and access to medicines
Sigrid Sterckx
Developing World Bioethics, 2004
View PDFchevron_right
Assessing the Impact of Field-of-Use Restrictions in Patent Licensing Agreements: The Ethical Pharmaceutical Industry in the United States, 1950–1962
Mar Cebrian
Enterprise & Society, 2017
View PDFchevron_right
A cross-country index of intellectual property rights in pharmaceutical inventions
Sumner La Croix
Research Policy, 2015
View PDFchevron_right
Towards a New Dialectics - Pharmaceutical Patents, Public Health and Foreign Direct Investments
valentina vadi
International Economic Law eJournal, 2015
View PDFchevron_right
Guidelines for the examination of pharmaceutical patents
carlos correa
View PDFchevron_right
Patents and Other Incentives for Pharmaceutical Innovation
Paul Grootendorst
Encyclopedia of Health Economics, 2014
View PDFchevron_right
Book Review The political economy of pharmaceutical patents
Ismail Lagardien
View PDFchevron_right
Analysis Patent Activity of Organizations and Manufacturers Concerning Pharmaceutical Products
Fidan Rustamli
Law Bulletin, 2020
View PDFchevron_right
How do the Social Benefits and Costs of the Patent System Stack Up in Pharmaceuticals?
Daniel Gifford
Bepress Legal Series, 2004
View PDFchevron_right
Pharmaceutical patents, R&D incentives and access to new drugs: new ways of progress at the crossroad
Fernando Antoñanzas
The European Journal of Health Economics, 2011
View PDFchevron_right
The pharmaceutical industry as a political player
John Abraham
View PDFchevron_right
Strategic Patenting by Pharmaceutical Companies – Should Competition Law Intervene?
Olga Gurgula
IIC - International Review of Intellectual Property and Competition Law
View PDFchevron_right
Courts and Pharmaceutical Patents: From Formalist Positivism to the Emergence of a Global Law
Vitor Ido
Access to Medicines and Vaccines
View PDFchevron_right
Shaping Global Rules: Proprietary Pharmaceutical Companies as Global Political Actors
Valbona Muzaka
View PDFchevron_right
Guidelines for the Examination of Pharmaceutical Patents: Developing a Public Health Perspective, ICTSD, WHO, UNCTAD, Geneva
carlos correa
View PDFchevron_right
Patents and Pharmaceutical R&D: Consolidating Private–Public Partnership Approach to Global Public Health Crises
Chidi Oguamanam
View PDFchevron_right
Strong patent rights accelerate the diffusion of new medicines across countries
Mark Schankerman
2017
View PDFchevron_right
Prizes for Pharmaceuticals? Mitigating the Social Ineffectiveness of the Current Pharmaceutical Patent Arrangement
Valbona Muzaka
View PDFchevron_right
Compulsory Licensing of Patented Pharmaceutical Inventions: Evaluating the Options
Jerome Reichman
Edward Elgar Publishing eBooks, 2013
View PDFchevron_right
The legal situation of the question of intellectual property for new treatment in the pharmaceutical industry, with its advantages and drawbacks
Ndu-metu Charles
View PDFchevron_right